肛管鳞状细胞癌的疫苗接种：当前及新兴疗法
Vaccinations for Anal Squamous Cancer: Current and Emerging Therapies.
作者信息
Berry John, Glasgow Sean C
机构信息
Division of Colon and Rectal Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
出版信息
Clin Colon Rectal Surg. 2018 Nov;31(6):321-327. doi: 10.1055/s-0038-1668101. Epub 2018 Nov 2.
Abstract
Human papillomavirus (HPV) infection is responsible for 4.3% of the global cancer burden. Since 2006, current HPV vaccines have reduced the prevalence of the virus in adolescent girls, reduced the prevalence of genital warts, and been proven to reduce the progression of anal intraepithelial neoplasia in men. Herein, we review the epidemiology, virology, and immunology behind the prophylactic HPV vaccines and current recommendations for its use. We also review future immune therapies being trialed for use against HPV-related cancers including anal cancer.
摘要
人乳头瘤病毒（HPV）感染导致了全球4.3%的癌症负担。自2006年以来，现有的HPV疫苗降低了青春期女孩中该病毒的流行率，降低了尖锐湿疣的发病率，并且已被证明可减少男性肛门上皮内瘤变的进展。在此，我们综述预防性HPV疫苗背后的流行病学、病毒学和免疫学，以及其目前的使用建议。我们还综述了正在试验用于治疗包括肛门癌在内的HPV相关癌症的未来免疫疗法。
相似文献
1
Vaccinations for Anal Squamous Cancer: Current and Emerging Therapies.肛管鳞状细胞癌的疫苗接种：当前及新兴疗法
Clin Colon Rectal Surg. 2018 Nov;31(6):321-327. doi: 10.1055/s-0038-1668101. Epub 2018 Nov 2.
2
Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review.女性肛门人乳头瘤病毒感染及肛门HPV相关疾病的患病率：一项系统评价
Am J Obstet Gynecol. 2015 Sep;213(3):278-309. doi: 10.1016/j.ajog.2015.03.034. Epub 2015 Mar 19.
3
The Human Papillomavirus Vaccine: Current Perspective and Future Role in Prevention and Treatment of Anal Intraepithelial Neoplasia and Anal Cancer.人乳头瘤病毒疫苗：当前视角及其在肛管上皮内瘤变和肛管癌预防与治疗中的未来作用
Oncologist. 2016 Apr;21(4):453-60. doi: 10.1634/theoncologist.2015-0075. Epub 2016 Mar 9.
4
Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults.HIV 感染者的肛门上皮内瘤变和鳞状细胞癌。
HIV Med. 2014 Feb;15(2):65-76. doi: 10.1111/hiv.12080. Epub 2013 Sep 6.
5
Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.人乳头瘤病毒与生殖器疣：对 2015 年美国疾病控制与预防中心性传播疾病治疗指南证据的综述。
Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S849-55. doi: 10.1093/cid/civ813.
6
Cytological Anal Squamous Intraepithelial Lesions Associated with Anal High-Risk Human Papillomavirus Infections among Men Who Have Sex with Men in Northern Thailand.泰国北部男男性行为者中与肛门高危型人乳头瘤病毒感染相关的细胞学肛管鳞状上皮内病变
PLoS One. 2016 May 26;11(5):e0156280. doi: 10.1371/journal.pone.0156280. eCollection 2016.
7
[HPV vaccination in boys and men : update and recommendations].[男孩和男性的人乳头瘤病毒疫苗接种：更新与建议]
Rev Med Brux. 2018;39(4):352-358.
8
New Insights into the Role of Human Papillomavirus in Anal Cancer and Anal Wart Development.人乳头瘤病毒在肛管癌和肛门疣发展中作用的新见解
Acta Cytol. 2019;63(2):118-123. doi: 10.1159/000491815. Epub 2019 Mar 12.
9
Oncogenic human papillomavirus is not helpful for cytology screening of the precursor lesions of anal cancers in Taiwanese men who are infected with human immunodeficiency virus.致癌性人乳头瘤病毒对感染人类免疫缺陷病毒的台湾男性肛门癌前病变的细胞学筛查并无帮助。
Int J Clin Oncol. 2015 Oct;20(5):943-51. doi: 10.1007/s10147-015-0804-9. Epub 2015 Feb 25.
10
HPV infection in women: psychosexual impact of genital warts and intraepithelial lesions.女性人乳头瘤病毒感染：尖锐湿疣和上皮内病变的性心理影响
J Sex Med. 2009 Mar;6(3):633-45. doi: 10.1111/j.1743-6109.2008.01151.x. Epub 2009 Jan 13.
引用本文的文献
1
Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer.肛管癌分子与治疗领域的新进展及未来机遇
Nat Rev Clin Oncol. 2025 May 13. doi: 10.1038/s41571-025-01025-x.
本文引用的文献
1
Prevalence of HPV in Adults Aged 18-69: United States, 2011-2014.18至69岁成年人中人类乳头瘤病毒（HPV）的流行情况：美国，2011 - 2014年
NCHS Data Brief. 2017 Apr(280):1-8.
2
Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions.过去十年中结直肠癌的癌症疫苗：经验教训与未来方向。
Expert Rev Clin Immunol. 2017 Mar;13(3):235-245. doi: 10.1080/1744666X.2016.1226132. Epub 2016 Aug 30.
3
Gaining ground on a cure through synergy: combining checkpoint inhibitors with cancer vaccines.通过协同作用取得治愈进展：将检查点抑制剂与癌症疫苗相结合。
Expert Rev Clin Immunol. 2016 Dec;12(12):1347-1357. doi: 10.1080/1744666X.2016.1202114. Epub 2016 Jun 28.
4
Prolonged antiretroviral therapy is associated with fewer anal high-grade squamous intraepithelial lesions in HIV-positive MSM in a cross-sectional study.在一项横断面研究中，长期抗逆转录病毒治疗与HIV阳性男男性行为者中较少的肛管高级别鳞状上皮内病变相关。
Sex Transm Infect. 2017 Feb;93(1):15-17. doi: 10.1136/sextrans-2015-052444. Epub 2016 Mar 30.
5
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.九价人乳头瘤病毒（HPV）疫苗的使用：免疫实践咨询委员会的HPV疫苗接种最新建议
MMWR Morb Mortal Wkly Rep. 2015 Mar 27;64(11):300-4.
6
Regression of human papillomavirus intraepithelial lesions is induced by MVA E2 therapeutic vaccine.MVA E2治疗性疫苗可诱导人乳头瘤病毒上皮内病变消退。
Hum Gene Ther. 2014 Dec;25(12):1035-49. doi: 10.1089/hum.2014.024.
7
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).人乳头瘤病毒疫苗接种：免疫实践咨询委员会（ACIP）的建议。
MMWR Recomm Rep. 2014 Aug 29;63(RR-05):1-30.
8
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.美国 HPV 疫苗接种后年轻女性 HPV 流行率降低，全国健康和营养调查，2003-2010 年。
J Infect Dis. 2013 Aug 1;208(3):385-93. doi: 10.1093/infdis/jit192. Epub 2013 Jun 19.
9
Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination.美国私人健康计划参与者中肛门生殖器疣的流行率，2003-2010 年：人乳头瘤病毒疫苗接种的潜在影响。
Am J Public Health. 2013 Aug;103(8):1428-35. doi: 10.2105/AJPH.2012.301182. Epub 2013 Jun 13.
10
The biology and life-cycle of human papillomaviruses.人乳头瘤病毒的生物学与生命周期。
Vaccine. 2012 Nov 20;30 Suppl 5:F55-70. doi: 10.1016/j.vaccine.2012.06.083.
Zotero 插件